Mohamed F Doheim: Clarifying the Role of Late IV Thrombolysis in the Era of Endovascular Therapy
Mohamed F Doheim, Assistant Professor in Neurology (Clinical Research), NIH StrokeNet Fellow at the University of Pittsburgh School of Medicine, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Neurology, adding:
”Excited to share my second publication in Neurology in a single day; this time on extended-window IV thrombolysis (IVT) for acute ischemic stroke (4.5–24 hours).
Across 18 RCTs and 5,168 patients, extended-window IVT improved excellent and good functional outcomes and reduced disability on the full mRS spectrum, with the expected increase in sICH but no excess mortality.
The central insight is why trial results have looked so heterogeneous.
Using multivariable meta-regression, we found that the main driver of between-study heterogeneity is whether patients also have access to endovascular thrombectomy (EVT).
Once EVT context is accounted for, much of the apparent variability in IVT effect becomes explainable.
Clinically, this means extended-window IVT may offer its greatest benefit in settings where thrombectomy is unavailable or delayed, especially for more severe strokes, positioning late IVT as a critical global reperfusion strategy rather than a niche protocol.
Proud to help clarify how IVT and EVT interact across trials and health systems, and to contribute evidence that can inform both guideline discussions and stroke systems of care worldwide.”
Title: Exploring Between-Study Heterogeneity in Extended-Window IV Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis of 18 Randomized Controlled Trials
Authors: Mohamed F. Doheim, Abdullah M. Al-Qudah, Romil Singh, Nirav R. Bhatt, Marcelo Rocha, Lawrence R. Wechsler, Gaoting Ma, Gisele Sampaio Silva, Sheila Co Martins, Chunrong Tao, Junwei Hao, Yamei Tang, Wei Hu, Lee H. Schwamm, Thanh N. Nguyen, Raul G. Nogueira

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 27, 2026, 04:50A Significant Step Forward for People with Bleeding Disorders in the Dominican Republic – WFH
-
Jul 27, 2026, 03:50Françoise Dignat-George: The Rising Impact of Extracellular Vesicles Spotlighted at ISTH 2026
-
Jul 27, 2026, 03:42Koson Tony Sriamporn: A Milestone for Inclusive Blood Donor Eligibility
-
Jul 27, 2026, 03:34Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026
-
Jul 26, 2026, 23:18Mohammadmahdi Sabahi: Proud to Share Our Complete Cushing’s Disease Research Collection
-
Jul 26, 2026, 22:59Mahmood Naseri: The Results of the 2nd Clinical Trial on AriClot Are Now Live in Burns Journal
-
Jul 26, 2026, 16:26Novi Yanti Sari: When MPNs Affect the Heart
-
Jul 26, 2026, 16:21Beyond Drugs: Can Museums Become a Medical Prescription?
-
Jul 26, 2026, 14:45Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research